pyrrolidonecarboxylic acid has been researched along with Cognition Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arendt, T; Cynis, H; Demuth, HU; Hartlage-Rübsamen, M; Jäger, C; Kehlen, A; Koch, B; Kreuzberger, M; Morawski, M; Roßner, S; Schilling, S; Waniek, A | 1 |
| Caldarone, BJ; Demuth, HU; Frost, JL; Kleinschmidt, M; Le, KX; Lemere, CA; Liu, B; Lues, I; O'Nuallain, B; Rahfeld, JU; Schilling, S | 1 |
2 other study(ies) available for pyrrolidonecarboxylic acid and Cognition Disorders
| Article | Year |
|---|---|
Glutaminyl cyclase in human cortex: correlation with (pGlu)-amyloid-β load and cognitive decline in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aminoacyltransferases; Amyloid beta-Peptides; Cognition Disorders; Entorhinal Cortex; Female; Humans; Male; Neurons; Psychiatric Status Rating Scales; Pyrrolidonecarboxylic Acid; RNA, Messenger; Temporal Lobe | 2014 |
An anti-pyroglutamate-3 Aβ vaccine reduces plaques and improves cognition in APPswe/PS1ΔE9 mice.
Topics: Alzheimer Disease; Alzheimer Vaccines; Amyloid beta-Peptides; Animals; Antibodies, Monoclonal; Brain; Cognition; Cognition Disorders; Immunization, Passive; Male; Mice, Inbred C57BL; Mice, Transgenic; Plaque, Amyloid; Pyrrolidonecarboxylic Acid | 2015 |